Literature DB >> 10482102

Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy.

D S Greenfield1, J M Liebmann, R Ritch.   

Abstract

PURPOSE: To describe an unusual hemorrhagic complication associated with pupillary dilation in a patient with exfoliation glaucoma taking anticoagulation therapy.
METHODS: A 78-year-old woman with bilateral exfoliation glaucoma who was receiving warfarin, 2 mg daily, for systemic anticoagulation developed acute visual loss in the right eye several hours after pupillary dilation. RESULT: Examination disclosed bilateral advanced exfoliation glaucoma, localized vascularized iridolenticular adhesions in the right eye, and a 4-mm layered hyphema in the right eye.
CONCLUSION: Patients with exfoliation glaucoma and vascularized posterior synechiae who are receiving anticoagulation therapy are at increased risk for visually significant spontaneous hyphema after pupillary dilation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482102     DOI: 10.1016/s0002-9394(99)00024-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Spontaneous hyphaema in a patient on warfarin treatment.

Authors:  Alessandro Bagnis; Silvio Lai; Michele Iester; Luca Bacino; Carlo Enrico Traverso
Journal:  Br J Clin Pharmacol       Date:  2008-07-15       Impact factor: 4.335

2.  [Massive subretinal hemorrhage and anticoagulants. An unfortunate combination?].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

Review 3.  Spontaneous hyphema and pupillary block in a patient with a left ventricular assist device.

Authors:  Shaheen C Kavoussi; Ji Liu
Journal:  Digit J Ophthalmol       Date:  2015-06-11

4.  Intravitreal anti-vascular endothelial growth factor injections to treat post-trabeculectomy Swan syndrome.

Authors:  Silvia Feu-Basilio; Barbara Romero-Nuñez; Néstor Ventura-Abreu; Josep Torras-Sanvicens; Marc Figueras-Roca; Marta Pazos
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.